Phreesia, Inc. (NYSE:PHR) SVP Sells $128,903.20 in Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 4,720 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total value of $128,903.20. Following the completion of the sale, the senior vice president now directly owns 110,309 shares of the company’s stock, valued at $3,012,538.79. This represents a 4.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Amy Beth Vanduyn also recently made the following trade(s):

• On Wednesday, January 15th, Amy Beth Vanduyn sold 604 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $16,295.92.
• On Monday, January 6th, Amy Beth Vanduyn sold 1,311 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $34,885.71.
• On Tuesday, December 3rd, Amy Beth Vanduyn sold 25,447 shares of Phreesia stock. The stock was sold at an average price of $20.93, for a total transaction of $532,605.71.

Phreesia Trading Down 0.2 %

PHR traded down $0.06 during midday trading on Wednesday, hitting $27.29. The company’s stock had a trading volume of 389,445 shares, compared to its average volume of 386,096. The firm has a market cap of $1.59 billion, a P/E ratio of -18.56 and a beta of 0.94. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.16. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a 50-day moving average price of $23.77 and a two-hundred day moving average price of $22.94.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. During the same period last year, the company posted ($0.58) EPS. The business’s quarterly revenue was up 16.6% on a year-over-year basis. On average, research analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on PHR shares. KeyCorp upped their price target on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Truist Financial boosted their price objective on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Robert W. Baird dropped their target price on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 price target on shares of Phreesia in a report on Friday, January 10th. Finally, Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and raised their price objective for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia presently has an average rating of “Buy” and an average target price of $31.00.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Champlain Investment Partners LLC grew its stake in Phreesia by 4.1% during the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after buying an additional 97,847 shares during the period. Franklin Resources Inc. increased its holdings in Phreesia by 3.0% in the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares in the last quarter. State Street Corp raised its position in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares during the period. Geode Capital Management LLC lifted its stake in shares of Phreesia by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after purchasing an additional 55,934 shares in the last quarter. Finally, TimesSquare Capital Management LLC grew its stake in shares of Phreesia by 2.3% in the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock valued at $19,791,000 after buying an additional 19,395 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.